Fineline Cube

Follow:
14437 Articles
Takeda Reports 2.8% Revenue Growth in Fiscal 2024, Driven by Product Sales
Company

Takeda Reports 2.8% Revenue Growth in Fiscal 2024, Driven by Product Sales

Zai Lab Reports Q1 2025 Revenue Growth and Pipeline Progress
Company

Zai Lab Reports Q1 2025 Revenue Growth and Pipeline Progress

Shanghai BDgene's BD111 Gene Therapy Advances to Phase II Clinical Trials
CompanyDrug

Shanghai BDgene’s BD111 Gene Therapy Advances to Phase II Clinical Trials

Prudential Hong Kong Collaborates with Foshan Fosun Chancheng Hospital for Direct Payment Services
CompanyDeals

Prudential Hong Kong Collaborates with Foshan Fosun Chancheng Hospital for Direct Payment Services

Sanyou Medical Partners with CGBio to Launch Regenerative Medicine Joint Venture
CompanyDeals

Sanyou Medical Partners with CGBio to Launch Regenerative Medicine Joint Venture

Hengrui Pharma Files for New Dalpiciclib Indication in Early Breast Cancer
CompanyDrug

Hengrui Pharma Files for New Dalpiciclib Indication in Early Breast Cancer

Gilead Sciences Announces $11 Billion Investment in US Expansion
CompanyDeals

Gilead Sciences Announces $11 Billion Investment in US Expansion

Humanwell Healthcare Gains NMPA Approval for Giapreza Generic in Shock Therapy
CompanyDrug

Humanwell Healthcare Gains NMPA Approval for Giapreza Generic in Shock Therapy

Humanwell Healthcare Gains NMPA Clearance for HZ-J001 Cream in Vitiligo Trial
CompanyDrug

Humanwell Healthcare Gains NMPA Clearance for HZ-J001 Cream in Vitiligo Trial

Pfizer Partners with HSITP to Boost Life Sciences Innovation in Greater Bay Area
CompanyDeals

Pfizer Partners with HSITP to Boost Life Sciences Innovation in Greater Bay Area

Insilico Medicine Files for IPO to Leverage AI in Drug Discovery
CompanyDeals

Insilico Medicine Files for IPO to Leverage AI in Drug Discovery

Pfizer's Zavicefta Approved by China's NMPA for Severe Infections in All Ages
CompanyDrug

Pfizer’s Zavicefta Approved by China’s NMPA for Severe Infections in All Ages